STOCKHOLM - March 17, 2020 - Fredrik Palm, CEO in ContextVision, has on March
13, 2020 purchased 300 shares in ContextVision AB at an average price of NOK 65
per share. After the transaction, Mr Palm holds a total of 1500 shares in
ContextVision AB.

For further information, please contact ContextVision's CEO, Fredrik Palm, at
+46 76 870 25 43 or visit www.contextvision.com.

                                      ###

About ContextVision

ContextVision is a medical technology software company that specializes in image
analysis and artificial intelligence. As the global market leader within image
enhancement, ContextVision is a software partner to leading medical imaging
manufacturers around the world. Its cutting-edge technology helps doctors
accurately interpret medical images, a crucial foundation for better diagnosis
and treatment.

As an industry pioneer for more than 30 years, ContextVision has developed
state-of-the-art capabilities in the latest artificial intelligence
technologies. By combining these with its well-established GOP technology, the
company is introducing a new generation of image enhancement products.
ContextVision are determined to expand by approaching the growing digital
pathology market with new AI-based decision support tools for pathologists.

The company is based in Sweden, with local representation in the U.S., Russia,
Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under
the ticker COV.


This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act